• Login
    View Item 
    •   UMB Digital Archive
    • School, Graduate
    • Theses and Dissertations All Schools
    • View Item
    •   UMB Digital Archive
    • School, Graduate
    • Theses and Dissertations All Schools
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of UMB Digital ArchiveCommunitiesPublication DateAuthorsTitlesSubjectsThis CollectionPublication DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    Display statistics

    A Role For RUNX2 And TAZ In Promoting A Tumorigenic Phenotype In Luminal Breast Cancer Cells

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    Brusgard_umaryland_0373D_10589.pdf
    Size:
    3.375Mb
    Format:
    PDF
    Download
    Author
    Brusgard, Jessica
    Advisor
    Passaniti, Antonino
    Date
    2014
    Type
    dissertation
    
    Metadata
    Show full item record
    Abstract
    Breast cancer (BC) is the second leading cause of cancer-associated deaths among women. Current strategies aimed at eradicating the primary tumor by targeting the bulk population of cells often leads to BC recurrence and metastasis because of intratumoral heterogeneity and treatment resistance. The RUNX2 transcription factor is upregulated in early stage luminal BC and is a poor prognostic indicator of patient survival. However, the precise mechanisms by which RUNX2 regulates an oncogenic phenotype in early stage tumors are not known. We now show for the first time that RUNX2 promotes luminal BC cell tumorsphere formation, which was inhibited with a novel RUNX2-targeting drug. RUNX2 associated with the TAZ transcriptional coactivator in MCF7 cells to promote a tumorigenic phenotype that was inhibited by siRNA-targeted knockdown of TAZ. TGFβ treatment of cells expressing RUNX2 increased endogenous TAZ translocation to the nucleus, a process that was prevented by inhibiting RUNX2. This translocation was preceded by disruption of adherens junctions through ectodomain shedding of an oncogenic soluble E-Cadherin fragment (80kDa sE-Cad). RUNX2 expression increased HER2-mediated tumorsphere formation, which was abrogated after treatment with the HER2-targeting agents Herceptin and Lapatinib. These data support a novel role for RUNX2 in promoting early stage tumorigenesis in the context of TGFβ, the Hippo signaling mediator TAZ, sE-Cad, and HER2. Using this signaling pathway to monitor BC cell oncogenic activity will allow us to discover new anti-cancer agents. Further characterization of RUNX2-targeted compounds that disrupt this oncogenic pathway could have therapeutic potential.
    Description
    University of Maryland, Baltimore. Molecular Medicine. Ph.D. 2014
    Keyword
    cell signaling
    E-cadherin
    RUNX2
    TAZ
    tumorigenesis
    Breast--Cancer
    Identifier to cite or link to this item
    http://hdl.handle.net/10713/4370
    Collections
    Theses and Dissertations School of Medicine
    Theses and Dissertations All Schools

    entitlement

     
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Policies | Contact Us | UMB Health Sciences & Human Services Library
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.